Results 221 to 230 of about 95,168 (297)

Synergistic Strategies in Systemic Therapy for Advanced Hepatocellular Carcinoma

open access: yesGlobal Challenges, Volume 10, Issue 1, January 2026.
This article comprehensively examines the evolving landscape of systemic therapy for advanced hepatocellular carcinoma. It covers the progress in tyrosine kinase inhibitors and immune checkpoint inhibitors, analyzes the efficacy of novel combination strategies, and discusses current challenges like drug resistance and the lack of biomarkers.
Yongxin Yu   +5 more
wiley   +1 more source

Global Health Initiatives and Universal Health Coverage in Pakistan‐Aligned for the Future?

open access: yesThe International Journal of Health Planning and Management, Volume 41, Issue 1, Page 156-170, January 2026.
ABSTRACT There is increasing global discourse on Global Health Initiatives' (GHIs) role and the need for better alignment with universal health coverage (UHC), which is particularly salient given recent rapid reductions in global aid. However, tensions within national ecosystems of GHI assistance and country alignment towards UHC are less well ...
Shehla Zaidi   +8 more
wiley   +1 more source

Knowledge and Prevalence of Hepatitis B and C Viral Infections Among Beauticians: A Cross‐Sectional Study in the Ejisu‐Juaben Municipality of the Ashanti Region, Ghana

open access: yesHealth Science Reports, Volume 9, Issue 1, January 2026.
ABSTRACT Background and Aims Procedures used by beauticians pose a significant risk of transmitting blood‐borne viruses, including hepatitis B virus (HBV) and hepatitis C virus (HCV). Despite this risk, data on HBV and HCV prevalence and knowledge among beauticians in Ghana are limited.
Kezia Y. Awortwe   +5 more
wiley   +1 more source

Hepatitis B Vaccine Refusal Trends in Washington, DC, Newborns, 2017-2022.

open access: yesJAMA Netw Open
Yang YT, Leslie TF, Delamater PL.
europepmc   +1 more source

Immune response to hepatitis B vaccine among children under 5 years in Africa: a meta-analysis. [PDF]

open access: yesTrop Med Health
Olakunde BO   +6 more
europepmc   +1 more source

Anti‐PD‐1/PD‐L1 Immunotherapy as a Potential Treatment Option for Lung Cancer: A Perspective Analysis of Opportunities and Challenges

open access: yesHealth Science Reports, Volume 9, Issue 1, January 2026.
ABSTRACT Background and Aims Anti‐PD‐1/PD‐L1 immunotherapy has changed the treatment landscape of lung cancer. This new approach provides the ability to revitalize the immune system to specifically target and kill cancer cells, thereby creating a new treatment paradigm for patients with non‐small cell lung cancer (NSCLC).
Md Mohiuddin
wiley   +1 more source

Efficacy of Hepatitis B vaccine in those who lost Hepatitis B surface antigen during follow-up: Efficacy of HBV vaccine in those who lost HBsAg.

open access: green, 2011
Hassan Taheri   +4 more
openalex   +1 more source

Home - About - Disclaimer - Privacy